154 related articles for article (PubMed ID: 9716027)
1. MIB-1 labelling index is an independent prognostic marker in primary breast cancer.
Jansen RL; Hupperets PS; Arends JW; Joosten-Achjanie SR; Volovics A; Schouten HC; Hillen HF
Br J Cancer; 1998 Aug; 78(4):460-5. PubMed ID: 9716027
[TBL] [Abstract][Full Text] [Related]
2. Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer.
Rudolph P; Alm P; Heidebrecht HJ; Bolte H; Ratjen V; Baldetorp B; Fernö M; Olsson H; Parwaresch R
J Natl Cancer Inst; 1999 Feb; 91(3):271-8. PubMed ID: 10037106
[TBL] [Abstract][Full Text] [Related]
3. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1.
Keshgegian AA; Cnaan A
Am J Clin Pathol; 1995 Jul; 104(1):42-9. PubMed ID: 7611179
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer.
Neri A; Marrelli D; Pedrazzani C; Caruso S; De Stefano A; Mariani F; Megha T; De Marco G; Corso G; Pinto E; Roviello F
Eur J Surg Oncol; 2008 Dec; 34(12):1299-303. PubMed ID: 18164172
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein.
Domagala W; Markiewski M; Harezga B; Dukowicz A; Osborn M
Clin Cancer Res; 1996 Jan; 2(1):147-54. PubMed ID: 9816101
[TBL] [Abstract][Full Text] [Related]
6. The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer.
Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma VM; Syrjänen K
J Cancer Res Clin Oncol; 1996; 122(11):687-92. PubMed ID: 8898980
[TBL] [Abstract][Full Text] [Related]
7. The role of MIB-1 index in the prognosis of resectable pancreatic head cancer.
Shyr YM; Su CH; Li AF; Wu CW; Lui WY
Hepatogastroenterology; 1999; 46(29):2968-73. PubMed ID: 10576384
[TBL] [Abstract][Full Text] [Related]
8. Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer.
Thor AD; Liu S; Moore DH; Edgerton SM
J Clin Oncol; 1999 Feb; 17(2):470-7. PubMed ID: 10080587
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of MIB-1 index and DNA ploidy in resectable ampulla of Vater carcinoma.
Shyr YM; Su CH; Wu LH; Li AF; Chiu JH; Wu CW; Lui WY
Ann Surg; 1999 Apr; 229(4):523-7. PubMed ID: 10203085
[TBL] [Abstract][Full Text] [Related]
10. MIB-1 and S-phase cell fraction predict survival in non-Hodgkin's lymphomas.
Mochen C; Giardini R; Costa A; Silvestrini R
Cell Prolif; 1997 Jan; 30(1):37-47. PubMed ID: 9332493
[TBL] [Abstract][Full Text] [Related]
11. The prognostic relevance of estimates of proliferative activity in early breast cancer.
Offersen BV; Sørensen FB; Knoop A; Overgaard J;
Histopathology; 2003 Dec; 43(6):573-82. PubMed ID: 14636258
[TBL] [Abstract][Full Text] [Related]
12. A simple index to predict prognosis independent of axillary node information in breast cancer.
Seshadri R; Horsfall DJ; McCaul K; Leong AS
Aust N Z J Surg; 1997 Nov; 67(11):765-70. PubMed ID: 9396991
[TBL] [Abstract][Full Text] [Related]
13. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
[TBL] [Abstract][Full Text] [Related]
14. Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis.
Seshadri R; Leong AS; McCaul K; Firgaira FA; Setlur V; Horsfall DJ
Int J Cancer; 1996 Apr; 69(2):135-41. PubMed ID: 8608982
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer.
Brown RW; Allred CD; Clark GM; Osborne CK; Hilsenbeck SG
Clin Cancer Res; 1996 Mar; 2(3):585-92. PubMed ID: 9816207
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas.
Stanton KJ; Sidner RA; Miller GA; Cummings OW; Schmidt CM; Howard TJ; Wiebke EA
Am J Surg; 2003 Nov; 186(5):486-92. PubMed ID: 14599612
[TBL] [Abstract][Full Text] [Related]
17. Analysis of correlation between mitotic index, MIB1 score and S-phase fraction as proliferation markers in invasive breast carcinoma. Methodological aspects and prognostic value in a series of 257 cases.
Caly M; Genin P; Ghuzlan A A; Elie C; Fréneaux P; Klijanienko J; Rosty C; Sigal-Zafrani B; Vincent-Salomon A; Douggaz A; Zidane M; Sastre-Garau X
Anticancer Res; 2004; 24(5B):3283-8. PubMed ID: 15510624
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer.
Dettmar P; Harbeck N; Thomssen C; Pache L; Ziffer P; Fizi K; Jänicke F; Nathrath W; Schmitt M; Graeff H; Höfler H
Br J Cancer; 1997; 75(10):1525-33. PubMed ID: 9166949
[TBL] [Abstract][Full Text] [Related]
19. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
Masood S; Bui MM; Lu L
Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
[TBL] [Abstract][Full Text] [Related]
20. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
Veronese SM; Maisano C; Scibilia J
Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
